Clinical Biochemistry Practice Questions

Q: Gastrin is a biochemical marker for which of the following tumors?

Pancreatic neuroendocrine tumor. **Explanation:** **Gastrin** is a peptide hormone primarily produced by the G-cells of the gastric antrum and the duodenum. In a clinical oncology context, it serves as a specific biochemical marker for **Gastrinomas**. 1. **Why Option B is Correct:** Gastrinomas are a type of **Pancreatic Neuroendocrine Tumor (PanNET)**. While they can occur in the "Gastrinoma Triangle" (duodenum, pancreas, and porta hepatis), the pancreas is a classic site. These tumors hypersecrete gastrin, leading to **Zollinger-Ellison Syndrome (ZES)**, characterized by severe peptic ulcer disease and chronic diarrhea due to excessive gastric acid production. 2. **Why Other Options are Incorrect:** * **A. Medullary Carcinoma of Thyroid (MCT):** The primary biochemical marker is **Calcitonin**. Carcinoembryonic antigen (CEA) is also used for monitoring. * **C. Pheochromocytoma:** This tumor of the adrenal medulla secretes catecholamines. The diagnostic markers are urinary and plasma **Metanephrines** and Vanillylmandelic acid (VMA). * **D. Gastrointestinal Stromal Tumor (GIST):** These are mesenchymal tumors. The most important diagnostic marker is the expression of the **CD117 (c-KIT)** protein, identified via immunohistochemistry. **High-Yield Clinical Pearls for NEET-PG:** * **Gastrinoma Triangle:** Bound by the junction of the cystic and common bile duct, the junction of the 2nd and 3rd parts of the duodenum, and the neck of the pancreas. * **MEN-1 Association:** Approximately 25% of gastrinomas are associated with Multiple Endocrine Neoplasia Type 1 (3Ps: Parathyroid, Pancreas, Pituitary). * **Diagnostic Test:** The **Secretin Stimulation Test** is the provocative test of choice; a paradoxical rise in serum gastrin levels confirms a gastrinoma.

Q: Which one of the following conditions is associated with unconjugated hyperbilirubinemia?

Gilbert syndrome. ### Explanation Hyperbilirubinemia is classified into **unconjugated (indirect)** and **conjugated (direct)** based on whether the defect occurs before or after the bilirubin is processed by the enzyme **UDP-glucuronosyltransferase (UGT1A1)** in the liver. **1. Why Gilbert Syndrome is Correct:** Gilbert syndrome is a common, benign autosomal recessive condition characterized by **reduced activity of UGT1A1** (typically ~30% of normal). This leads to impaired conjugation of bilirubin, resulting in isolated **unconjugated hyperbilirubinemia**. It typically manifests as mild jaundice triggered by stress, fasting, or illness. **2. Analysis of Other Options:** * **Crigler-Najjar Syndrome:** This condition also causes unconjugated hyperbilirubinemia. Type I involves a total absence of UGT1A1, while Type II involves a severe deficiency (<10%). **Note:** While Crigler-Najjar is technically correct, in many MCQ formats, if "All of the above" is provided but the specific source/context emphasizes the most common benign cause or if the question implies a specific clinical scenario, Gilbert is often the focus. However, strictly speaking, both A and C cause unconjugated hyperbilirubinemia. * **Rotor Syndrome:** This is a defect in the **hepatic storage/reuptake** of bilirubin. It results in **conjugated hyperbilirubinemia**. * **Dubin-Johnson Syndrome (Related):** Caused by a defect in the **MRP2 transporter**, leading to impaired excretion of conjugated bilirubin into the bile (also **conjugated hyperbilirubinemia**). **High-Yield Clinical Pearls for NEET-PG:** * **Unconjugated (Indirect):** Gilbert, Crigler-Najjar, Hemolysis. * **Conjugated (Direct):** Dubin-Johnson (Black liver), Rotor (No black liver). * **Phenobarbital:** Used to treat Crigler-Najjar Type II and Gilbert as it induces UGT1A1 activity. * **Diagnostic Test:** In Gilbert syndrome, jaundice increases with a **48-hour fast** (Caloric restriction test).

Q: Which of the following most closely represents the lowest detection limit for third-generation TSH assays?

0.04 mIU/L. **Explanation:** The evolution of TSH assays is defined by their **functional sensitivity**, which is the lowest concentration of TSH that can be measured with a coefficient of variation (CV) of less than 20% [1]. This sensitivity determines the assay's ability to distinguish between suppressed and subnormal TSH levels [1]. * **Correct Answer (B):** Third-generation TSH assays have a functional sensitivity of **0.01 to 0.02 mIU/L**, though they are broadly categorized by a detection limit of **0.01–0.05 mIU/L**. Therefore, **0.04 mIU/L** is the most accurate representation among the choices. These assays are the current clinical standard, allowing clinicians to distinguish between mild (subclinical) hyperthyroidism and profound TSH suppression seen in overt Graves' disease [1]. **Analysis of Incorrect Options:** * **Option A (0.4 mIU/L):** This represents the lower limit of the **normal reference range** for TSH in healthy adults, not the detection limit of the assay itself. * **Option C (0.004 mIU/L):** This corresponds to **fourth-generation assays**, which have a sensitivity of <0.005 mIU/L. While highly sensitive, they are primarily used in research settings and are not the standard "third-generation" assays used in routine practice. * **Option D (0.0004 mIU/L):** This value is beyond the capability of current clinical diagnostic technology. **High-Yield Clinical Pearls for NEET-PG:** * **Generations Rule of 10:** Each generation is roughly 10 times more sensitive than the previous one: * 1st Gen: 1.0 mIU/L * 2nd Gen: 0.1 mIU/L * 3rd Gen: 0.01 mIU/L * **Clinical Utility:** Third-generation assays are essential for monitoring **Levothyroxine suppression therapy** in thyroid cancer patients and for diagnosing **Subclinical Hyperthyroidism** (Low TSH with normal T3/T4) [1]. * **Best Initial Test:** Serum TSH is the single most sensitive and specific test for screening thyroid dysfunction [1].

Q: What does the HbA1c level in blood explain?

Long-term status of blood sugar. Explanation: **HbA1c (Glycated Hemoglobin)** is the gold standard for monitoring glycemic control in patients with Diabetes Mellitus. It represents the percentage of hemoglobin that has glucose chemically linked to it through a non-enzymatic process called **glycation** [3]. 1. **Why Option B is Correct:** The binding of glucose to hemoglobin is irreversible and depends directly on the ambient glucose concentration [1]. Since the average lifespan of a Red Blood Cell (RBC) is approximately **120 days**, the HbA1c level reflects the average blood glucose levels over the preceding **2–3 months** [2]. This makes it an ideal marker for assessing the **long-term status of blood sugar** rather than daily fluctuations [1], [2]. 2. **Why Other Options are Incorrect:** * **Option A:** Acute rises in blood sugar (post-prandial spikes or stress hyperglycemia) are measured using Fasting Blood Sugar (FBS) or Post-Prandial Blood Sugar (PPBS). HbA1c remains stable despite acute daily changes. * **Option C & D:** Hepatorenal syndrome (renal failure in the setting of liver cirrhosis) and Chronic pancreatitis (inflammation of the pancreas) are distinct clinical entities. While chronic pancreatitis can lead to secondary diabetes (Type 3c), HbA1c is a marker of the resulting glucose levels, not the disease process itself. **High-Yield Clinical Pearls for NEET-PG:** * **Diagnostic Threshold:** An HbA1c **≥ 6.5%** is diagnostic for Diabetes Mellitus. * **False Lows:** Conditions that decrease RBC lifespan (e.g., Hemolytic anemia, acute blood loss, Pregnancy, Erythropoietin therapy) will falsely lower HbA1c. * **False Highs:** Conditions that increase RBC lifespan (e.g., Iron deficiency anemia, Vitamin B12 deficiency) or Splenectomy can falsely elevate HbA1c. * **Formula:** Estimated Average Glucose (eAG) = $28.7 \times \text{HbA1c} - 46.7$.

Q: A 56-year-old man with a 14-year history of diabetes mellitus presents with poor vision, peripheral vascular disease, and mild proteinuria. Which of the following is the best monitor of the control of blood sugar levels in this patient?

Glycosylated hemoglobin. ### Explanation **Correct Answer: A. Glycosylated hemoglobin (HbA1c)** The patient presents with chronic complications of diabetes mellitus (retinopathy, peripheral vascular disease, and nephropathy). In such cases, long-term glycemic control is crucial. **Why HbA1c is the best monitor:** HbA1c is formed by the **non-enzymatic glycation** of the N-terminal valine of the beta chain of hemoglobin. Since the average lifespan of a Red Blood Cell (RBC) is **120 days**, HbA1c provides a retrospective index of the average blood glucose levels over the preceding **8–12 weeks (2–3 months)**. Unlike blood glucose levels, it is not affected by recent diet or exercise, making it the gold standard for monitoring long-term compliance and treatment efficacy. **Why other options are incorrect:** * **B. Islet cell autoantibody:** These are markers used to diagnose **Type 1 Diabetes Mellitus** (autoimmune etiology) rather than monitoring glucose control. * **C & D. Serum myoinositol and Sorbitol:** These are involved in the **Polyol Pathway** (Sorbitol pathway). In hyperglycemia, glucose is converted to sorbitol by aldose reductase, leading to osmotic damage (cataracts, neuropathy). While they are part of the pathogenesis of diabetic complications, they are not used clinically to monitor blood sugar levels. --- ### NEET-PG High-Yield Pearls * **HbA1c Targets:** For most diabetic patients, the target is **< 7%**. A level of **≥ 6.5%** is diagnostic for Diabetes. * **Fructosamine (Glycated Albumin):** Reflects glycemic control over the past **2–3 weeks**. It is useful in patients with hemolytic anemia or hemoglobinopathies where HbA1c is unreliable. * **False Low HbA1c:** Seen in conditions that decrease RBC lifespan (e.g., Hemolytic anemia, acute blood loss, Pregnancy). * **False High HbA1c:** Seen in conditions that increase RBC lifespan (e.g., Splenectomy) or Iron deficiency anemia.

Q: A patient's lipid profile shows Triglycerides (TG) of 200 mg/dL, Total Cholesterol of 300 mg/dL, and HDL of 40 mg/dL. Calculate the LDL level in this patient.

220 mg/dL. To calculate the LDL (Low-Density Lipoprotein) cholesterol level, we use the **Friedewald Formula**, which is a high-yield concept for NEET-PG Biochemistry. ### **The Formula:** **LDL = Total Cholesterol – HDL – (Triglycerides / 5)** *(Note: TG/5 represents VLDL cholesterol, provided TG levels are <400 mg/dL).* ### **Step-by-Step Calculation:** 1. **Identify the values:** Total Cholesterol = 300, HDL = 40, TG = 200. 2. **Calculate VLDL:** TG / 5 = 200 / 5 = **40 mg/dL**. 3. **Calculate LDL:** 300 – 40 (HDL) – 40 (VLDL) = **220 mg/dL**. ### **Analysis of Options:** * **C (220 mg/dL):** Correct. This is the result of the standard Friedewald calculation. * **A (40 mg/dL):** Incorrect. This represents only the HDL or the calculated VLDL component. * **B (100 mg/dL):** Incorrect. This might result from a calculation error or confusing the target LDL level with the calculated one. * **D (260 mg/dL):** Incorrect. This value is obtained if one forgets to subtract the VLDL (TG/5) component (300 - 40 = 260). ### **Clinical Pearls for NEET-PG:** * **Limitation:** The Friedewald formula is **invalid** if Triglycerides are **>400 mg/dL** or if the patient has Type III Hyperlipoproteinemia (Dysbetalipoproteinemia). * **Sample Requirement:** For an accurate lipid profile, a **12-14 hour fasting** sample is preferred to minimize the impact of chylomicrons on TG levels. * **Direct LDL:** If TG >400 mg/dL, LDL must be measured directly using ultracentrifugation or homogenous assays rather than the formula.

Q: Rothera's test is used for detecting which substance in urine?

Ketone bodies. **Explanation:** **Rothera’s test** is the standard biochemical method used to detect **Ketone bodies** in urine. The test utilizes **Sodium Nitroprusside** in the presence of alkali (ammonia). It specifically reacts with **acetoacetate** and **acetone** to produce a characteristic **permanganate-colored (purple/violet) ring** at the junction of the fluids. Note that it does not detect beta-hydroxybutyrate, which is the predominant ketone body in diabetic ketoacidosis. **Analysis of Incorrect Options:** * **A. Bilirubin:** Detected using **Fouchet’s test**, where barium chloride is used to precipitate bilirubin, followed by the addition of Fouchet’s reagent to produce a green/blue color. * **B. Glucose:** Detected using **Benedict’s test**, which relies on the reducing property of glucose to convert cupric ions to cuprous oxide, resulting in a color change from blue to brick red. * **C. Protein:** Commonly detected using the **Heat and Acetic Acid test** (coagulation) or the **Sulphosalicylic acid test** (turbidity). **High-Yield Clinical Pearls for NEET-PG:** * **Gerhardt’s Test:** Specifically detects acetoacetate (using ferric chloride) but is less sensitive than Rothera’s. * **Ketone Body Composition:** In DKA, the ratio of $\beta$-hydroxybutyrate to acetoacetate increases significantly. Since Rothera’s test only detects the latter, it may initially underestimate the severity of ketosis. * **False Positives:** Drugs containing sulfhydryl groups (e.g., Captopril, Penicillamine) can give a false-positive Rothera’s test. * **Hay’s Test:** Used for detecting **Bile Salts** (based on surface tension).

Question 1

Gastrin is a biochemical marker for which of the following tumors?

Accepted Answer

Pancreatic neuroendocrine tumor

Answer

Medullary carcinoma of thyroid

Answer

Pheochromocytoma

Answer

Gastrointestinal stromal tumor

Question 2

Which of the following is not typically found in nephrotic syndrome?

Accepted Answer

Increased LDL-Cholesterol

Answer

Increased Triglycerides (TG)

Answer

Decreased HDL-Cholesterol

Answer

Increased VLDL-Cholesterol

Question 3

Which one of the following conditions is associated with unconjugated hyperbilirubinemia?

Accepted Answer

Gilbert syndrome

Answer

Rotors syndrome

Answer

Crigler-Najjar syndrome

Answer

All of the above

Question 4

False positive D-xylose test may be seen in which of the following conditions?

Accepted Answer

All of the above

Answer

Blind loop syndrome

Answer

Ascites

Answer

Antibiotic therapy

Question 5

Which of the following most closely represents the lowest detection limit for third-generation TSH assays?

Accepted Answer

0.04 mIU/L

Answer

0.4 mIU/L

Answer

0.004 mIU/L

Answer

0.0004 mIU/L

Question 6

What does the HbA1c level in blood explain?

Accepted Answer

Long-term status of blood sugar

Answer

Acute rise of blood sugar

Answer

Hepatorenal syndrome

Answer

Chronic pancreatitis

Question 7

Which substance is often confused with protein in certain biochemical tests?

Accepted Answer

Phosphates

Answer

Nitrates

Answer

Sulphates

Answer

Bile salts

Question 8

A 56-year-old man with a 14-year history of diabetes mellitus presents with poor vision, peripheral vascular disease, and mild proteinuria. Which of the following is the best monitor of the control of blood sugar levels in this patient?

Accepted Answer

Glycosylated hemoglobin

Answer

Islet cell autoantibody

Answer

Serum myoinositol

Answer

Serum sorbitol

Question 9

A patient's lipid profile shows Triglycerides (TG) of 200 mg/dL, Total Cholesterol of 300 mg/dL, and HDL of 40 mg/dL. Calculate the LDL level in this patient.

Accepted Answer

220 mg/dL

Answer

40 mg/dL

Answer

100 mg/dL

Answer

260 mg/dL

Question 10

Rothera's test is used for detecting which substance in urine?

Accepted Answer

Ketone bodies

Answer

Bilirubin

Answer

Glucose

Answer

Protein

Clinical Biochemistry — MCQs

Clinical Biochemistry — MCQs

On this page

Practice by Chapter

Want unlimited practice?